Effect of atorvastatin on no-reflow phenomenon after emergency percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

ZHOU Yingfeng

doi:10.7619/jcmp.201902012

Journal of Clinical Medicine in Practice > 2019 > (2): 40-43. > DOI: 10.7619/jcmp.201902012

ZHOU Yingfeng. Effect of atorvastatin on no-reflow phenomenon after emergency percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2019, (2): 40-43. DOI: 10.7619/jcmp.201902012

Citation:

PDF (275 KB)

Effect of atorvastatin on no-reflow phenomenon after emergency percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

ZHOU Yingfeng

More Information

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Cited By

Cited by

Periodical cited type(8)

1.	庄云. 急性胰腺炎患者血清CysC、IL-18、Hcy表达及其用于急性肾损伤风险预测中的临床价值. 医学理论与实践. 2025(06): 1009-1011 .
2.	王祥龙，魏天宁，赖志文，王信杰，王振扬. 血清Hcy与老年胆囊结石患者术后并发胰腺炎的关系. 中国老年学杂志. 2024(05): 1062-1065 .
3.	黄燕平. 益生菌联合大剂量维生素C在重症急性胰腺炎中的应用及潜在机制分析. 实用临床医药杂志. 2024(17): 56-61 . 本站查看
4.	荣曾霞，熊绘，杨勋能. 低晶胶比液体复苏完成时限对成人重症急性胰腺炎休克患者病情及转归的影响. 实用临床医药杂志. 2024(23): 81-86 . 本站查看
5.	朱芳丽，马晓莹，杨悦，乔红，刘烨，马厉英，韩俊岭. 血清S100A12、Hcy及ACE2与重症急性胰腺炎预后的关系研究. 转化医学杂志. 2024(05): 670-676 .
6.	王明东. 血清ICAM-1、SIL-2R、IL-2水平与急性胰腺炎病情程度的相关性分析. 山西卫生健康职业学院学报. 2023(01): 29-31 .
7.	王丽杰，李娜，何君，吕德全. 血清Hcy、TNF-α及sIL-2R水平与急性胰腺炎患者病情严重程度及预后的关系. 分子诊断与治疗杂志. 2023(10): 1778-1781+1786 .
8.	侯燕燕，陈新卫，田颖，谢晨星，战海涛. 连续性肾脏替代治疗联合限制性液体复苏在重症急性胰腺炎治疗中的应用价值. 陕西医学杂志. 2023(12): 1711-1714 .

Other cited types(1)

Get Citation

PDF

XML

Article views (175) PDF downloads (6) Cited by(9)

Turn off MathJax

Article Contents

Effect of atorvastatin on no-reflow phenomenon after emergency percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

Cited by

Periodical cited type(8)

Other cited types(1)

Catalog

Export File

Citation

Format

Content